Key result
In patients with cardiac amyloidosis, transpulmonary gradient (HR 0.88; 95% CI 0.80-0.97) and right ventricular ejection fraction were significantly associated with major adverse cardiovascular events.
Why the study?
While cardiac amyloidosis classically involves the left ventricle, its impact on the right ventricle and pulmonary vasculature is less known.
Cohort (n=52)
Hazard Ratio: 0.88 (95% CI 0.8–0.97)
In patients with cardiac amyloidosis, pulmonary hypertension is highly prevalent (mostly isolated postcapillary), and transpulmonary gradient and right ventricular ejection fraction are significant prognostic markers for MACE.
PH common in CA but haemodynamic profile non-prognostic; leaves open whether PH-targeted therapy improves outcomes.
OBJECTIVES: While cardiac amyloidosis (CA) classically involves the left ventricle (LV), less is known about its impact on the right ventricle (RV) and pulmonary vasculature. We performed a retrospective analysis to identify the prevalence and types of pulmonary hypertension (PH) profiles in CA and to determine haemodynamic and cardiovascular magnetic resonance (CMR) predictors of major adverse cardiovascular events (MACE). METHODS: Patients with CA who underwent CMR and right heart catheterisation (RHC) within 1 year between 2010 and 2019 were included. Patients were assigned the following haemodynamic profiles based on RHC: no PH, precapillary PH, isolated postcapillary PH (IPCPH), or combined precapillary and postcapillary PH (CPCPH). The relationship between PH profile and MACE (death, heart failure hospitalisation) was assessed using survival analysis. CMR and RV parameters were correlated with MACE using Cox-regression analysis. RESULTS: A total of 52 patients were included (age 69±9 years, 85% men). RHC was performed during biopsy in 44 (85%) and for clinical indications in 8 (15%) patients. Rates of no PH, precapillary PH, IPCPH and CPCPH were 5 (10%), 3 (6%), 29 (55%) and 15 (29%), respectively. Haemodynamic PH profile did not correlate with risk of death (p=0.98) or MACE (p=0.67). Transpulmonary gradient (TPG) (HR 0.88, CI 0.80 to 0.97), RV, (HR 0.95, CI 0.92 to 0.98) and LV ejection fraction (HR 0.95, CI 0.92 to 0.98) were significantly associated with MACE. CONCLUSIONS: PH is highly prevalent in CA, even at the time of diagnosis. While IPCPH was most common, CPCPH is not infrequent. TPG and RV ejection fraction (RVEF) are prognostic markers in this population.
No takes yet. Share an insight, caveat, or question.
Slivnick et al. (2022) conducted a cohort in Cardiac amyloidosis (n=52). Transpulmonary gradient (TPG) was evaluated on Major adverse cardiovascular events (death, heart failure hospitalisation) (HR 0.88, 95% CI 0.80 to 0.97). In patients with cardiac amyloidosis, transpulmonary gradient (HR 0.88; 95% CI 0.80-0.97) and right ventricular ejection fraction were significantly associated with major adverse cardiovascular events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: